ZyVersa Therapeutics Inc. (ZVSA) — Strategic Asset Allocation Index
ZyVersa Therapeutics Inc. (ZVSA) has a Strategic Asset Allocation Index of 0.1% as of December 2022. Strategic assets (PP&E of $115.70K plus long-term investments of $-) total $115.70K, measured against net assets of $99.99 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
ZyVersa Therapeutics Inc. Strategic Asset Allocation Index (2022–2022)
This chart shows how ZyVersa Therapeutics Inc.'s Strategic Asset Allocation Index has evolved across 1 annual periods from 2022 to 2022. As of December 2022, the index stands at 0.1%, representing strategic assets of $115.70K against net assets of $99.99 Million USD. Explore ZVSA cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for ZyVersa Therapeutics Inc. (2022–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for ZyVersa Therapeutics Inc. from 2022 to 2022, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see ZyVersa Therapeutics Inc. (ZVSA) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.1% | $115.70K | $115.70K | $- | $99.99 Million | — |